BCN —:— Diagnostic
[ Overview ]

Web design for pharmaceutical companies

Pharmaceutical web design for laboratories and healthcare companies: regulated content, multiple audiences and markets within one sustainable architecture.

Sector

[ Overview ]

The approach is defined before it becomes a set of screens.

What it needs to solve
Web design for pharmaceutical companies

The project starts with the decision the digital presence needs to support, the information behind it and the operations the team needs to sustain. This way, design and technology respond to a specific need.

[ A clear way of working ]

A clear way of working

01

Context before form

Proposition, audience, content and objectives are organised before a visual direction is set.

02

Structure that supports

Navigation, content and actions are shaped around the questions that arise throughout the journey.

03

A foundation that evolves

The system is prepared so the team can maintain and extend it with sound judgement.

[ Overview ]

Let’s discuss the project

  • Analysis of context, audience and starting point
  • Information architecture and content priorities
  • Visual direction, interface and development
  • Measurement, maintenance and ongoing evolution
[ For this assignment ]

Web design for pharmaceutical companies

Strategy, content, design and implementation are organised around the organisation’s context. Decisions are documented so the team has a clear foundation for launch, maintenance and future development.

[ Related project ]

Laboratorios Rubió 2024

View the project ↗
[ In detail ]

Web design for pharmaceutical companies

A legal notice is not an architecture

The usual way of separating healthcare professionals from the general public is an overlay that asks visitors to confirm a status and then shows them exactly the same thing. It does not satisfy the regulatory requirement and it degrades the experience for everyone. The separation has to live in the structure: which sections exist for each audience, what gets indexed, what sits behind genuine access control. Decided that way, it stops being a patch and becomes something the regulatory team can validate once and sign off.

The site freezes when everything counts as regulated content

At many laboratories publishing anything has become slow because no distinction is made between what needs review and what does not. A corporate press release, a job posting or a change to the company page end up queuing behind product content. Marking within the system itself which content types carry a validation workflow and which do not frees most of the editorial activity without relaxing a single requirement that matters.

Several markets without ending up with parallel websites

A laboratory operating across several countries usually ends up with sites that started identical and no longer resemble each other: different structure, different published portfolio, different version of the same text. Bringing them onto a shared base and allowing them to diverge only where regulation or product range demands it cuts maintenance to a fraction, and above all stops content corrected in one market from staying wrong in the other three.

[ FAQ ]

Before deciding

What should be prepared before starting?

The material you already have and an honest picture of who visits the site and with what question. In this sector content weighs more than the template, and it usually sets the timeline.

How is the scope of Web design for pharmaceutical companies defined?

It starts from the decisions your audience makes before getting in touch, and the site is built around them. The scope comes from that, not from a standard list of sector sections.

Is new photography needed?

Almost always, and it is worth budgeting from the start. In this field original photography is the real differentiator; stock makes two competitors look like the same company.

How is it checked before going live?

With the journeys that genuinely get used in this sector, on the device people actually arrive from — usually a phone, usually in a hurry. The data that has to stay current is reviewed too.

How is the result measured?

By better-prepared enquiries: people arriving knowing what you offer and asking the right question. That is the signal the team notices before any chart.

What happens after launch?

It is settled who updates what and how often, because content dates quickly in this sector. If needed, a seasonal follow-up is agreed.

[ Related work ]

Related work

A selection of work showing context, decisions and outcomes.

Allergy Therapeutics Ibérica
Allergy Therapeutics Ibérica
Consulte su vacuna
Consulte su vacuna
Laboratorios Rubió
Laboratorios Rubió
RubioID
RubioID
Actúa Pharma
Actúa Pharma
[ Where to go next ]

What usually comes next

[ Let’s discuss the project ]

Let’s discuss the project

Tell us where things stand and we can assess the most useful approach for the project.